MPXA-2000

K222036

Medipixel, Inc. · cleared 2023-03-22 · product code QIH · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.5)
MPXA-2000, the stand-alone application, is cardiovascular image analysis software for the viewing and quantification of X-ray angiographic images of the coronary arteries.
AlgorithmDeep-learning (Classification and Segmentation of vessels) and Computer vision algorithms (Measurements of vessels)
source quote (p.5)
MPXA-2000 is developed based on Deep-learning (Classification and Segmentation of vessels) and Computer vision algorithms (Measurements of vessels) to analyze the images and provide quantification of the vessels in real-time.
Adaptive (vs locked)No
source quote (p.8)
The Deep-learning algorithm used in MPXA-2000 was validated by the standalone performance test (Doc. No. TD-XA2-SPTR) using the method of comparing the analysis results obtained from MPXA-2000 with the ground truth annotated by experienced experts.
PCCPFDA source did not state this
Cybersecurity addressedYes
source quote (p.9)
A cybersecurity verification testing was conducted to demonstrate the integrity, confidentiality, and availability of MPXA-2000 through testing for identified vulnerabilities of product.

Validation studies (1)

Retrospective clinical

n=305 images

endpoints: vessel segmentation assessment; vessel classification assessment; ROI analysis assessment

standards: IEC 62304 Edition 1.1 2015-06 Medical device software - Software life cycle processes, General Principles of Software Validation (Jan 11, 2002), Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices: Guidance for Industry and FDA Staff (Nov 05, 2005), Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, (Oct 2, 2014)

Reported performance (2 observations)

accuracyas written: “vessel classification accuracy0.9934
source quote (p.8)
The vessel classification accuracy: 0.9934
diceas written: “vessel segmentation Dice similarity Coefficient (DSC)0.92
source quote (p.8)
The vessel segmentation Dice similarity Coefficient (DSC): 0.9200(Pass criteria of > 0.8)

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
3
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K222036